Ischemia-modified albumin in patients with seizure

Sevket Balta; Mustafa Aparci; Mustafa Demir; Cengiz Ozturk; Turgay Celik

doi:10.1016/j.ajem.2014.06.028

Switch to Standard View Switch to Enhanced View

Ischemia-modified albumin in patients with seizure☆

Sevket Balta, MD

Department of Cardiology, Eskişehir Military Hospital, Eskişehir, Turkey

Department of Cardiology, Etimesgut Military Hospital, Ankara, Turkey

Mustafa Aparci, MD

Department of Cardiology, Gulhane Medical Academy Ankara, Turkey

Mustafa Demir, MD

Cengiz Ozturk, MD

Turgay Celik, MD

Department of Cardiology, Eskişehir Military Hospital, Eskişehir, Turkey

Department of Cardiology, Etimesgut Military Hospital, Ankara, Turkey

Department of Cardiology, Gulhane Medical Academy Ankara, Turkey

DOI: http://dx.doi.org/10.1016/j.ajem.2014.06.028

Article Info

Purchase this article (PDF Included)

$31.50 USD (24 hour access)

Subscribe to this title

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

We read the article “Novel biochemical marker for differential diagnosis of seizure: Ischemia modified albumin” by Uzel et al [1]. They aimed to evaluate and investigate the diagnostic value of ischemia-modified albumin (IMA) in adult patients presented to emergency department with seizures. They demonstrated that blood IMA level and IMA/albumin ratio significantly increase in adult patients who experienced seizures. Ischemia-modified albumin may be considered as a useful biomarker in the differential diagnosis of seizure.

To access this article, please choose from the options below

Log In

Register

Create a new account

Purchase access to this article

$31.50 USD|Online access for 24 hours

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

☆There is no conflict of interests.

Ischemia-modified albumin in patients with seizure☆

Correspondence

Correspondence

Article Info

To access this article, please choose from the options below

Log In

Register

Purchase access to this article

Claim Access

Subscribe to this title

Institutional Access

Article Tools

Related Articles